Dergiler / Glokom Katarakt / 2021 / Cilt: 16 - Sayı: 3

Evaluation of Corneal Transparency in Eyes Treated with Brimonidine

Sayfa
131–137
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: The CT values in the central and zones of 2, 6 and 10 mm on day 3 after treatment were statistically significantly thicker when compared to baseline and controls (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose: The aim of this study was to evaluate the effects of topical 0.1% brimonidine on the corneal densitometry.
📊
Temel Bulgular & Veri:Materials and Methods: This prospective study included 32 eyes of 17 patients who were diagnosed with primary open angle glaucoma and treated with 0.1% brimonidine, and 28 eyes of 14 healthy individuals.
💡
Sonuç & Katkı:Results: The CT values in the central and zones of 2, 6 and 10 mm on day 3 after treatment were statistically significantly thicker when compared to baseline and controls (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Purpose: The aim of this study was to evaluate the effects of topical 0.1% brimonidine on the corneal densitometry. Materials and Methods: This prospective study included 32 eyes of 17 patients who were diagnosed with primary open angle glaucoma and treated with 0.1% brimonidine, and 28 eyes of 14 healthy individuals. Corneal densitometry and corneal thickness (CT) were evaluated in the three corneal zones (0-2, 2-6, 6-10) by Scheimpflug corneal topography at baseline and on day 3, 17 and 30 after the treatment. Results: The CT values in the central and zones of 2, 6 and 10 mm on day 3 after treatment were statistically significantly thicker when compared to baseline and controls (p

🔖

Bu Makaleye Atıf Yap

IRGAT, S. G., ÖZCURA, F., ALTUNEL, O. (2022). Evaluation of Corneal Transparency in Eyes Treated with Brimonidine. Glokom Katarakt, Cilt: 16 - Sayı: 3, 131–137. https://ajindex.com/articles/525739

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Fudemberg, S.J., Batiste, C., Katz, L.J. Efficacy, safety, and current applications of brimonidine. Expert Opin. Drug Saf. 2008;7:975-9
  2. Reitsamer H.A., Posey M., Kiel J.W. Effects of a topical alpha2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits. Exp. Eye Res. 2006;82:405-15
  3. Kalapesi F.B., Coroneo M.T., Hill M.A. Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection. Br. J. Ophthalmol. 2005;89:758-63
  4. Matthias G., Joerg M., Jens Martin R., et al. Effect of brimonidine on corneal thickness. 2011;27:503-9 5. Ozyol P, Ozyol E. Assessment of corneal backward light scattering in diabetic patients. Eye Contact Lens. 2018;44:92-6
  5. Ni Dhubhghaill S, Rozema JJ, Jongenelen S, et al. Normative values for corneal densitometry analysis by Scheimpflug optical assessment. Invest Ophthalmol Vis Sci 2014;55:162-8
  6. Lopes B, Ramos I, Ambrósio R Jr. Corneal densitometry in keratoconus. Cornea. 2014;33:1282-6
  7. Oliveira CM, Ribeiro C, Franco S. Corneal imaging with slit- scanning and Scheimpflug imaging techniques. Clin Exp Optom. 2011;94:33-42
  8. Becquet F, Goldschild M, Moldovan MS, et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res. 1998;17:419-25
  9. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490- 6
  10. Hamard P, Debbasch C, Blondin C, et al. Human trabecular cells and apoptosis: in vitro evaluation of the effect of betaxolol with or without preservative. J Fr Ophthalmol. 2002;25:777-84
  11. Osborne SA, Montgomery DM, Morris D, et al. Alphagan allergy may increase the propensity for multiple eye-drop allergy. Eye (Lond). 2005;19:129-37
  12. Manni G, Centofanti M, Sacchetti M, et al. Demographic and clinical factors associated with development of brimonidine tartrate 0.2%- induced ocular allergy. J Glaucoma. 2004;13:163- 7
  13. Manabe Y, Sawada A, Mochizuki K. Corneal sterile infiltration induced by topical use of ocular hypotensive agent. European Journal of Ophthalmology. 2020;30:23-5
  14. Tsujinaka A, Takai Y, Inoue Y, et al. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution. Acta Ophthalmologica, 2019;97:948-9
  15. Maruyama Y, Ikeda Y, Yokoi N et al. Severe corneal disorders developed after brimonidine tartrate